20th anniversary of TNF inhibitors in rheumatoid arthritis

20th anniversary of TNF inhibitors in rheumatoid arthritis

Detalhes bibliográficos
Autor principal:	Taylor, P
Formato:	Journal article
Publicado em:	Springer Healthcare 2019

Registos relacionados

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
Por: Cynthia Said, et al.
Publicado em: (2013-01-01)

The metabolic effects of TNF inhibitors in rheumatoid arthritis patients
Por: Alexandra Jitaru, et al.
Publicado em: (2019-12-01)

Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
Por: Taylor, P
Publicado em: (2001)

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
Por: Rosario Lopez-Rodriguez, et al.
Publicado em: (2018-01-01)

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients
Por: Chamaida Plasencia-Rodríguez, et al.
Publicado em: (2024-09-01)

Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
Por: Taylor, P
Publicado em: (2010)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
Por: Feldmann, M, et al.
Publicado em: (2011)

TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20
Por: Al-Bogami, M, et al.
Publicado em: (2020)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
Por: Taylor, P, et al.
Publicado em: (2009)

Plasma Sclerostin Levels in Rheumatoid Arthritis Women on TNF-α Inhibitor Therapy
Por: Anna Szeremeta, et al.
Publicado em: (2024-05-01)

Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both?
Por: Fatima Zamri, et al.
Publicado em: (2020-10-01)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
Por: Borja Hernández-Breijo, et al.
Publicado em: (2021-06-01)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
Por: Maini, R, et al.
Publicado em: (1993)

JAK inhibitors in rheumatoid arthritis
Por: Taylor, PC
Publicado em: (2019)

Non-TNF inhibitor switchers versus TNF inhibitor cyclers from multicentre rheumatoid arthritis ultrasonography prospective cohort in Japan
Por: Yushiro Endo, et al.
Publicado em: (2020-07-01)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
Por: Taylor, P, et al.
Publicado em: (2000)

20th Anniversary Editorial
Por: Maja Klun, et al.
Publicado em: (2022-11-01)

Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis.
Por: Bart V J Cuppen, et al.
Publicado em: (2016-01-01)

Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis
Por: Hull, D, et al.
Publicado em: (2016)

Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis.
Por: Hull, D, et al.
Publicado em: (2016)

Development of anti-TNF therapy for rheumatoid arthritis.
Por: Feldmann, M
Publicado em: (2002)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
Por: Maini, R, et al.
Publicado em: (1994)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
Por: Maini, R, et al.
Publicado em: (2000)

Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment
Por: Xuyang Xia, et al.
Publicado em: (2025-03-01)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
Por: Kim HJ, et al.
Publicado em: (2020-03-01)

Use of TNF-alpha inhibitors in rheumatoid arthritis and implications for the periodontal status: For the benefit of both?
Por: Teun de Vries, et al.
Publicado em: (2021-04-01)

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis
Por: Eulalia Rodríguez-Martín, et al.
Publicado em: (2020-08-01)

Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure
Por: Dong-Jin Park, et al.
Publicado em: (2022-04-01)

TNF alpha as a therapeutic target in rheumatoid arthritis.
Por: Feldmann, M, et al.
Publicado em: (1994)

The association of extended TNF haplotypes and susceptibility to rheumatoid arthritis
Por: Newton, J, et al.
Publicado em: (2001)

TNFα blockers and infectious risk in rheumatoid arthritis
Por: S. Todesco, et al.
Publicado em: (2011-06-01)

TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
Por: Bystrom, J, et al.
Publicado em: (2016)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
Por: E. A. Golikova, et al.
Publicado em: (2012-05-01)

To the 20th anniversary of the journal "Informatics"
Publicado em: (2024-03-01)

On the 20th Anniversary of Provincializing Europe
Por: José Neves, et al.
Publicado em: (2020-12-01)

20th anniversary of the Meteorologische Zeitschrift
Por: Stefan Emeis, et al.
Publicado em: (2012-02-01)

Preface to the 20th Anniversary Issue
Por: Peter Kim
Publicado em: (2021-05-01)

Celebrating our 20th Anniversary!
Por: Margaret E. Adamek
Publicado em: (2020-07-01)

The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes
Por: Vedran Premužić, et al.
Publicado em: (2020-01-01)

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts
Por: Bruno Fautrel, et al.
Publicado em: (2022-08-01)